Valrocemide

DB06657ExperimentalSmall molecule

Investigated for use/treatment in epilepsy.

Chemical structure of Valrocemide
Primary indication
Investigated for use/treatment in epilepsy.Curator reviewed
Formula / weight
C10H20N2O2 · 200.282 g/mol (avg)
Code names
TV-1901 · TVP-1901

Resolves to

Compound
UNII1C7GO6OW7LCAS92262-58-3ChEMBLCHEMBL471638
Structure
InChIKeyRALGCAOVRLYSMA-UHFFFAOYSA-NSMILESCCCC(CCC)C(=O)NCC(N)=O

Which companies are running trials of Valrocemide, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In